#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3606131	B	Inhibition of human recombinant MGAT2 assessed as reduction in enzyme-mediated deacylation of oleoyl-CoA incubated for 20 mins by CPM dye based fluorescence assay	Homo sapiens	17	ALA3603768	single protein format	Scientific Literature
2.	ALA3606133	P	Solubility in water		8	ALA3603768	small-molecule physicochemical format	Scientific Literature
3.	ALA3606134	P	Solubility in FeSSIF solution at pH 5.0		8	ALA3603768	small-molecule physicochemical format	Scientific Literature
4.	ALA3606135	A	Drug metabolism in human liver microsomes incubated for 15 mins	Homo sapiens	5	ALA3603768	assay format	Scientific Literature
5.	ALA3606136	A	Drug metabolism in mouse liver microsomes incubated for 15 mins	Mus musculus	5	ALA3603768	assay format	Scientific Literature
6.	ALA3705499	B	Inhibition Assay: A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood et al., Am. J. Physiol. Endocrinol. Metab., 2003, 285, E927.Bac-to-Bac Baculovirus Expression System (Life Technologies Japan) was used to express human MGAT2 in insect cells (Sf9) (Life Technologies Japan). These cells were sonicated and centrifuged at 100,000 g.times.1 hr to give a precipitate. The precipitate was used as a human MGAT2 enzyme fraction in this assay.This test was conducted using a black flat-bottom 96-well plate (Corning). A buffer solution with final concentrations of 5 mM magnesium chloride, 100 mM sucrose and 100 mM Tris-HCl (pH=7.5) was prepared and test compounds prepared in various concentrations using dimethyl sulfoxide were added thereto to give a final dimethyl sulfoxide concentration of 1%. The MGAT2 enzyme fraction was added thereto to give a final concentration of 0.5 .mu.g/ml.		96	ALA3638807	cell-based format	BindingDB Database